Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New personalized therapy aims to ease chronic jaw pain

NCT ID NCT04376333

Symptom relief Sponsor: UConn Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 21, 2026 · Updated 3 times

Summary

This study compares two behavioral treatments for temporomandibular joint disorders (TMD), a common cause of jaw and face pain. 160 adults with long-term jaw pain will receive either standard dental care plus a highly individualized coping skills program, or standard care plus conventional cognitive-behavioral therapy. The goal is to see which approach better reduces pain, depression, and daily interference, and to understand how coping skills affect outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive-behavioral coping skills training
What this could lead to
If successful, this could offer a more personalized, effective way to manage chronic jaw pain and improve daily functioning.
What could go wrong
This is a relatively small, early-stage behavioral study. Results may not apply to all TMD patients, and the treatment may not outperform standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2021

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age \> 18 years 2. Jaw pain \> 3 mo; \> 3/10 on pain scale 3. Positive Axis I diagnosis on the Diagnostic Criteria for temporomandibular disorders (DC/TMD), with or without disc displacement 4. Positive on \> 1 of: 1. Any myalgia diagnosis 2. Any myofascial diagnosis 3. Arthralgia 4. TMD-related Headache Exclusion Criteria: 1. Lack of fluency in English 2. Previous invasive surgery for TMD, not including arthrography or arthrocentesis 3. Extensive anatomical destruction or deterioration of the TM joint 4. Diagnosed as having pain of neuropathic or odontogenic origin 5. Carrying a diagnosis of psychosis 6. Taking narcotic pain medication 7. Any comorbid condition necessitating use of an intraoral appliance (e.g., obstructive sleep apnea) 8. Pregnancy (excluded due to prescription of NSAIDs)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Orofacial pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain Facial Pain temporomandibular joint disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Orofacial pain Temporomandibular joint disorders

Contacts and locations

Locations

  • UConn Health

    Farmington, Connecticut, 06030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.